0001209191-18-027652.txt : 20180503 0001209191-18-027652.hdr.sgml : 20180503 20180503163426 ACCESSION NUMBER: 0001209191-18-027652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ambrogi Michael J. CENTRAL INDEX KEY: 0001654363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 18804361 MAIL ADDRESS: STREET 1: 195 COMMERCE WAY CITY: PORTSMOUTH STATE: NH ZIP: 03801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-01 0 0001645113 Novocure Ltd NVCR 0001654363 Ambrogi Michael J. C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Operating Officer Ordinary Shares 2018-05-01 4 M 0 28695 3.44 A 175253 D Ordinary Shares 2018-05-01 4 M 0 31305 7.03 D 206558 D Ordinary Shares 2018-05-01 4 S 0 60000 27.40 D 146558 D Options to Buy Ordinary Shares 3.44 2018-05-01 4 M 0 8695 0.00 D 2021-12-13 Ordinary Shares 8695 20000 D Options to Buy Ordinary Shares 3.44 2018-05-01 4 M 0 20000 0.00 D 2021-12-13 Ordinary Shares 20000 0 D Options to Buy Ordinary Shares 7.03 2018-05-01 4 M 0 20000 0.00 D 2023-02-19 Ordinary Shares 20000 15195 D Options to Buy Ordinary Shares 7.03 2018-05-01 4 M 0 11305 0.00 D 2023-02-19 Ordinary Shares 11305 3890 D These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. On May 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 60,000 shares in multiple trades at prices ranging from $26.925 to $27.825. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested as of the date hereof. /s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi 2018-05-03